Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy
Cancer Cell International,
Abstract Extensive exploration of the molecular subtypes of triple-negative breast cancer (TNBC) is critical for advancing…